- Bullish trend confirmed on both short and long timeframes
- Consistently positive technical signals over the last month
- +40.8% YTD performance
Brooklyn Immunotherapeutics Inc stock upgraded to Strong Buy Candidate
(Updated on Jun 22, 2026)
The Brooklyn Immunotherapeutics Inc stock price gained 0.86% on the last trading day (Monday, 22nd Jun 2026), rising from $9.34 to $9.42. During the last trading day the stock fluctuated 1.34% from a day low at $9.32 to a day high of $9.44. The price has risen in 6 of the last 10 days and is up by 7.53% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 228 thousand more shares were traded than the day before. In total, 675 thousand shares were bought and sold for approximately $6.36 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 44.03% during the next 3 months and, with a 90% probability hold a price between $12.98 and $14.37 at the end of this 3-month period.
BTX Signals & Forecast
The Brooklyn Immunotherapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $9.18 and $8.78. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 8.65%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The stock had a Golden Star Signal on Tuesday, January 27, 2026 in the long-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Golden Star 12 Months
The stock had a Golden Star Signal on Tuesday, January 27, 2026 in the long-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Support, Risk & Stop-loss for Brooklyn Immunotherapeutics Inc stock
Brooklyn Immunotherapeutics Inc finds support from accumulated volume at $8.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.125 (1.34%) between high and low. For the last week, the stock has had daily average volatility of 2.08%.
Our recommended stop-loss: $9.05 (-3.92%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 7 days ago.)
Trading Expectations (BTX) For The Upcoming Trading Day Of Tuesday 23rd
For the upcoming trading day on Tuesday, 23rd we expect Brooklyn Immunotherapeutics Inc to open at $9.39, and during the day (based on 14 day Average True Range), to move between $9.29 and $9.55, which gives a possible trading interval of +/-$0.263 (+/-2.83%) up or down from last closing price. If Brooklyn Immunotherapeutics Inc takes out the full calculated possible swing range there will be an estimated 2.83% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $8.95, some $0.470 (4.99%) from the current price of $9.42, our system finds the risk reward attractive.
Is Brooklyn Immunotherapeutics Inc stock A Buy?
Brooklyn Immunotherapeutics Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.
Current score:
6.159
Strong Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 23, 2026 - $9.39 ( 0.301%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
BTX Performance
Trading levels for BTX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 9.52 | 1.03% |
| R2 | 9.47 | 0.519% |
| R1 | 9.44 | 0.206% |
| Price | 9.42 | |
| S1 | 9.34 | -0.81% |
| S2 | 9.31 | -1.12% |
| S3 | 9.27 | -1.63% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 9.42 | |
| S1 | 8.95 | -4.99% |
| S2 | 7.94 | -15.71% |
| S3 | 7.40 | -21.44% |
BTX Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Sep 15, 2026 | Sep 15, 2026 | Sep 30, 2026 | $0.0525 | 0.601% |
| 2 | Aug 14, 2026 | Aug 14, 2026 | Aug 31, 2026 | $0.0525 | 0.601% |
| 3 | Jul 15, 2026 | Jul 15, 2026 | Jul 31, 2026 | $0.0525 | 0.601% |
| 4 | Jun 15, 2026 | Jun 15, 2026 | Jun 30, 2026 | $0.0525 | 0.781% |
| 5 | May 15, 2026 | May 15, 2026 | May 29, 2026 | $0.0525 | 0.781% |
FAQ
Click here for our free guide on how to buy Brooklyn Immunotherapeutics Inc Stock.
Buy BTX